e-Therapeutics (ETX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

9.45p
   
  • Change Today:
    -0.33p
  • 52 Week High: 23.10
  • 52 Week Low: 8.13
  • Currency: UK Pounds
  • Shares Issued: 584.34m
  • Volume: 279,843
  • Market Cap: £55.22m

Deal with Barclays    Trade now with Barclays Stockbrokers

Latest Deals

Traded Action Notifier PriceAmountValue
09-Jan-24 Buy Trevor Mervyn Jones 8.28p 91,325 £7,561.71
06-Jul-23 Buy Trevor Mervyn Jones 21.71p 34,830 £7,561.59

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
09-Jan-24 Buy Trevor Mervyn Jones 8.28p 91,325 £7,561.71
06-Jul-23 Buy Trevor Mervyn Jones 21.71p 34,830 £7,561.59

Director Shareholdings

Notifier Holding Value*
Ali Mortazavi 50,941,666 £4,813,987
Trevor Mervyn Jones 1,293,896 £122,273
Michael Anthony Bretherton 500,000 £47,250

Major Shareholders

Notifier** Holding Value*
Richard Griffiths 170,510,905 £16,113,280
M&G Plc 101,875,000 £9,627,188
Robert Quested 52,000,000 £4,914,000
Trillian Ltd 29,769,326 £2,813,201
Henderson Global Investors 26,445,958 £2,499,143
David Richardson 24,779,030 £2,341,618
Lombard Odier Asset Management (Europe) Limited 20,965,820 £1,981,270
Rupert Labrum 17,162,547 £1,621,861
Gartmore Investment Limited 6,541,000 £618,124
Credit Suisse Client Nominees (UK) Limited 4,557,950 £430,726

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

e-Therapeutics Market Data

Currency UK Pounds
Share Price 9.45p
Change Today -0.33p
% Change -3.32 %
52 Week High 23.10
52 Week Low 8.13
Volume 279,843
Shares Issued 584.34m
Market Cap £55.22m

e-Therapeutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
22.84% below the market average22.84% below the market average22.84% below the market average22.84% below the market average22.84% below the market average
64.71% above the sector average64.71% above the sector average64.71% above the sector average64.71% above the sector average64.71% above the sector average
Price Trend
38.98% below the market average38.98% below the market average38.98% below the market average38.98% below the market average38.98% below the market average
34.55% above the sector average34.55% above the sector average34.55% above the sector average34.55% above the sector average34.55% above the sector average
Income Not Available
Growth
16.48% below the market average16.48% below the market average16.48% below the market average16.48% below the market average16.48% below the market average
25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average

e-Therapeutics Dividends

No dividends found

Trades for 02-May-2024

Time Volume / Share Price
13:06 44,315 @ 9.45p
13:06 100,000 @ 9.45p
13:04 25,000 @ 9.41p
13:00 6,000 @ 9.10p
11:47 137 @ 9.20p

e-Therapeutics Key Personnel

Chair Trevor Mervyn Jones
CEO Ali Mortazavi

Top of Page